Abstract
Intimal hyperplasia (IH) is the main cause of restenosis or occlusion after vascular procedures. Imatinib mesylate and rapamycin are known to prevent IH. The purpose of this study was to evaluate the effect of these drugs on the regression of preformed IH in rat carotid injury model. IH was established in rat carotid arteries using a balloon catheter. The drug effects were assessed in vitro on proliferation, migration, and apoptosis of vascular smooth muscle cells (VSMC) in the neointima. And in vivo studies were carried out in 4 groups: imatinib, rapamycin, combined, and no medication. After 2-week oral medication, morphometric analysis evaluated the number and density of neointimal cells, intima-to-media (I/M) ratio and cross-sectional area. Cell proliferation, apoptosis, and collagen changes were also investigated by immunohistochemical staining (IHCS). Imatinib and rapamycin significantly inhibited VSMC proliferation and migration, and promoted apoptosis in vitro. In morphometric analysis, the number and density of neointimal cells decreased significantly in all medication groups compared with control group (P < 0.01). However, there was no significant difference in neointimal cross-sectional area and I/M ratio among groups...Continue Reading
References
Jul 1, 1979·The Histochemical Journal·L C JunqueiraR R Brentani
Nov 1, 1973·Beiträge Zur Pathologie·H PuchtlerL S Valentine
Jun 1, 1993·Transplantation·C R GregoryR E Morris
Nov 5, 1997·Progress in Cardiovascular Diseases·C Bauters, J M Isner
May 5, 1999·Circulation·R SihvolaK Lemström
Oct 27, 1999·Gastroenterology·J ZhuM A Zern
Jan 4, 2001·Journal of Dermatological Science·J Uitto, D Kouba
Mar 19, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Allen M Gown, Mark C Willingham
Jun 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Kyung-Woo ParkKenneth Walsh
Sep 25, 2003·Langenbeck's Archives of Surgery·Fred FändrichBernd Kremer
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Oct 11, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Chad Johnson, Zorina S Galis
Oct 31, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Peter N RuygrokAnne Keogh
Feb 28, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Markus LassilaMark E Cooper
Mar 23, 2004·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Akimitsu NasunoYoshifusa Aizawa
Jul 21, 2004·Atherosclerosis·Mariam KloucheAlberto Mantovani
Sep 24, 2004·Journal of Molecular and Cellular Cardiology·Hyo-Soo KimMyoung-Mook Lee
Mar 23, 2005·The Journal of Experimental Medicine·Amir AbdollahiPeter E Huber
Sep 15, 2005·JAMA : the Journal of the American Medical Association·Gregg W StoneUNKNOWN TAXUS V Investigators
Nov 16, 2005·Circulation·Keith D DawkinsUNKNOWN TAXUS VI Investigators
Jan 18, 2006·Journal of Vascular Research·Joannis E VamvakopoulosPekka Hayry
Mar 8, 2006·Immunology and Cell Biology·Amit K MitraDevendra K Agrawal
Aug 18, 2006·The Journal of Biological Chemistry·Nicolas PoulalhonFranck Verrecchia
Aug 26, 2006·Circulation Research·Chao-Hung WangSubodh Verma
Dec 30, 2006·Arthritis and Rheumatism·Jörg H W DistlerOliver Distler
Jan 6, 2007·Journal of Cardiovascular Pharmacology·Christian M MatterThomas F Lüscher
Feb 13, 2007·International Journal of Cardiology·Jung-Won SuhYoung-Bae Park
Oct 24, 2007·Journal of Vascular Surgery·Seung-Kee MinAlexander W Clowes
Mar 5, 2009·Vascular Pharmacology·Karine VallièresGaétan Laroche